Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine established the Sylvester Pancreatic Cancer Research Institute. The center will support research, increase collaborations between scientists and clinicians, and provide more treatment and clinical trial opportunities for patients.
Anna Berkenblit, a clinical oncologist and drug developer, was named the first-ever chief scientific and medical officer of the Pancreatic Cancer Action Network.
